Clinical Trial Results
Research Sponsor: AstraZeneca
Drug Studied: Olaparib
Study Purpose: This trial was done to learn about the safety
of olaparib and how it works in participants
with advanced breast cancer.
Protocol Number: D0816C00018
Thank you
Thank you to the participants who took part in the clinical trial for the trial drug
olaparib, also called AZD2281.
All of the participants helped researchers learn more about olaparib to help
people with advanced breast cancer.
AstraZeneca sponsored this trial and believes it is important to share the results of
this trial with the participants and the public. AstraZeneca reviewed the results of
this trial when it ended and created a report of those results. This is a summary of
that report.
An independent non-profit organization called CISCRP helped prepare this
summary of the trial results. We hope it helps the participants understand and feel
proud of their important role in medical research.
If you participated in this trial and have questions about the results, please speak
with a trial doctor or staff at your trial site.
1